Modern VaccinesAdjuvants Formulation

15-17 May 2013, CHUV, Lausanne, Switzerland

  • Increase font size
  • Default font size
  • Decrease font size

Participation

Abstract Submissions

The MVAF 2013 Scientific Advisory Panel require authors to submit a one page abstract for each paper they wish to be considered for inclusion in the oral and/or poster programs during MVAF 2013. The one page abstract should contain sufficient information for the Scientific Advisory Panel to be able to make a valid decision as to the intrinsic merit of the paper and its relevance to the aims of the conference. Authors should indicate on the reply form whether they prefer oral or poster presentation. Proposals are also invited for panel discussions and special workshops – these special sessions may be scheduled during the daytime conference timetable or alternatively can be allocated as either breakfast or evening sessions.

Abstract proposals should be sent for the attention of John Herriot at Meetings Management (MVAF 2013 Conference Organisers). Authors should send their abstract(s) using the Call for Participation Reply Form or by e-mail to John Herriot (please attach abstracts as Word documents).

Closing date for submissions intended for oral presentation: Friday 23rd November 2012. Authors will be informed of the status of their contribution(s) in December 2012. Closing date for submissions intended for poster presentation: Friday 19th April 2013.

Publication

Abstracts of all papers to be presented (oral and poster) will be included in a CD ROM which will be distributed to delegates on registration.

Participation

All non-invited speakers will be expected to register as delegates to MVAF 2013. Registration will require speakers to pay a registration fee to attend the conference. Travel and accommodation expenses are the responsibility of each non-invited speaker and no direct compensation is awarded for speakers at MVAF 2013. Your submission of an abstract testifies to the fact that you will accept these financial conditions.

 

MVAF 2013 Delegates

Login details will be supplied after you have registered for the event.


MVAF 2013 Sponsors

  • Viscogel
  • Aldevron
  • Izon
  • Vedantra Pharmaceuticals
  • Novartis Vaccines
  • Sanofi Pasteur
  • Immune Design
  • DNA Vaccine
  • Pharvat
  • Dynavax
  • Brenntag
  • European Adjuvant Advisory Committee
  • Immune Solutions
  • CSL
  • Vaccine Formulation Laboratory
  • Intercell
  • Wittycell
  • Retroscreen Virology
  • IDRI
  • Univac
  • Vironova
  • Pfizer
  • Mucosis
  • Seppic
  • Inovio

MVAF 2013 Downloads

MVAF 2013 Leaflet

MVAF 2013 Mailing List

Name
E-mail Address
What is 1+4-2?